{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:42:49Z","timestamp":1793911369033,"version":"4.8.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NCCS intramural funds"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Epigenetics &amp; Chromatin"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Diabetic cardiomyopathy (DCM) is a leading cause of death in diabetic patients. Hyperglycemic myocardial microenvironment significantly alters chromatin architecture and the transcriptome, resulting in aberrant activation of signaling pathways in a diabetic heart. Epigenetic marks play vital roles in transcriptional reprogramming during the development of DCM. The current study is aimed to profile genome-wide DNA (hydroxy)methylation patterns in the hearts of control and streptozotocin (STZ)-induced diabetic rats and decipher the effect of modulation of DNA methylation by alpha-ketoglutarate (AKG), a TET enzyme cofactor, on the progression of DCM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Diabetes was induced in male adult Wistar rats with an intraperitoneal injection of STZ. Diabetic and vehicle control animals were randomly divided into groups with\/without AKG treatment. Cardiac function was monitored by performing cardiac catheterization. Global methylation (5mC) and hydroxymethylation (5hmC) patterns were mapped in the Left ventricular tissue of control and diabetic rats with the help of an enrichment-based (h)MEDIP-sequencing technique by using antibodies specific for 5mC and 5hmC. Sequencing data were validated by performing (h)MEDIP-qPCR analysis at the gene-specific level, and gene expression was analyzed by qPCR. The mRNA and protein expression of enzymes involved in the DNA methylation and demethylation cycle were analyzed by qPCR and western blotting. Global 5mC and 5hmC levels were also assessed in high glucose-treated DNMT3B knockdown H9c2 cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We found the increased expression of DNMT3B, MBD2, and MeCP2 with a concomitant accumulation of 5mC and 5hmC, specifically in gene body regions of diabetic rat hearts compared to the control. Calcium signaling was the most significantly affected pathway by cytosine modifications in the diabetic heart. Additionally, hypermethylated gene body regions were associated with Rap1, apelin, and phosphatidyl inositol signaling, while metabolic pathways were most affected by hyperhydroxymethylation. AKG supplementation in diabetic rats reversed aberrant methylation patterns and restored cardiac function. Hyperglycemia also increased 5mC and 5hmC levels in H9c2 cells, which was normalized by DNMT3B knockdown or AKG supplementation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study demonstrates that reverting hyperglycemic damage to cardiac tissue might be possible by erasing adverse epigenetic signatures by supplementing epigenetic modulators such as AKG along with an existing antidiabetic treatment regimen.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13072-023-00489-4","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T03:30:39Z","timestamp":1682566239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Epigenetic modifier alpha-ketoglutarate modulates aberrant gene body methylation and hydroxymethylation marks in diabetic heart"],"prefix":"10.1186","volume":"16","author":[{"given":"Rohini","family":"Dhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dattatray","family":"Mongad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivarupa","family":"Raji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silpa","family":"Arkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitish R.","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya L.","family":"Sitasawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"489_CR1","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"L Ryd\u00e9n","year":"2013","unstructured":"Ryd\u00e9n L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2013;34:3035\u201387.","journal-title":"Eur Heart J"},{"issue":"4","key":"489_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122:624\u201338.","journal-title":"Circ Res"},{"issue":"6","key":"489_CR3","doi-asserted-by":"publisher","first-page":"e022308","DOI":"10.1161\/JAHA.121.022308","volume":"11","author":"RM Inciardi","year":"2022","unstructured":"Inciardi RM, Claggett B, Gupta DK, Cheng S, Liu J, Tcheugui JBE, et al. Cardiac structure and function and diabetes-related risk of death or heart failure in older adults. J Am Heart Assoc. 2022;11:e022308.","journal-title":"J Am Heart Assoc"},{"key":"489_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-017-0506-x","author":"A Lorenzo-Almor\u00f3s","year":"2017","unstructured":"Lorenzo-Almor\u00f3s A, Tu\u00f1\u00f3n J, Orejas M, Cort\u00e9s M, Egido J, Lorenzo \u00d3. Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc Diabetol. 2017. https:\/\/doi.org\/10.1186\/s12933-017-0506-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"25","key":"489_CR5","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115:3213\u201323.","journal-title":"Circulation"},{"issue":"1","key":"489_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12933-016-0424-3","volume":"15","author":"M S\u00e1rk\u00f6zy","year":"2016","unstructured":"S\u00e1rk\u00f6zy M, Szucs G, Fekete V, Pipicz M, \u00c9der K, G\u00e1sp\u00e1r R, et al. Transcriptomic alterations in the heart of non-obese type 2 diabetic Goto-Kakizaki rats. Cardiovasc Diabetol. 2016;15:110.","journal-title":"Cardiovasc Diabetol"},{"key":"489_CR7","doi-asserted-by":"publisher","first-page":"84836","DOI":"10.3389\/fgene.2022.848364","volume":"13","author":"Y Xi","year":"2022","unstructured":"Xi Y, Chen D, Dong Z, Lam H, He J, Du K, et al. RNA sequencing of cardiac in a rat model uncovers potential target LncRNA of diabetic cardiomyopathy. Front Genet. 2022;13:84836.","journal-title":"Front Genet"},{"issue":"10","key":"489_CR8","doi-asserted-by":"publisher","first-page":"e0276076","DOI":"10.1371\/journal.pone.0276076","volume":"17","author":"Biao Feng","year":"2022","unstructured":"Endothelial derived miRNA-9 mediated cardiac fibrosis in diabetes and its regulation by ZFAS1","journal-title":"PlOS ONE"},{"issue":"1","key":"489_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41467-017-02762-z","volume":"9","author":"R Gilsbach","year":"2018","unstructured":"Gilsbach R, Schwaderer M, Preissl S, Gr\u00fcning BA, Kranzh\u00f6fer D, Schneider P, et al. Distinct epigenetic programs regulate cardiac myocyte development and disease in the human heart in vivo. Nat Commun. 2018;9:391.","journal-title":"Nat Commun"},{"key":"489_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01055-2","author":"Y Shi","year":"2022","unstructured":"Shi Y, Zhang H, Huang S, Yin L, Wang F, Luo P, et al. Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials. Signal Transduct Target Ther. 2022. https:\/\/doi.org\/10.1038\/s41392-022-01055-2.","journal-title":"Signal Transduct Target Ther"},{"key":"489_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2018.08.021.","volume":"837","author":"S Biswas","year":"2018","unstructured":"Biswas S, Rao CM. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy. Eur J Pharmacol. 2018;837:8\u201324.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"489_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38:23\u201338.","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"489_CR13","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2217\/epi.15.39","volume":"7","author":"Q Du","year":"2015","unstructured":"Du Q, Luu PL, Stirzaker C, Clark SJ. Methyl-CpG-binding domain proteins: readers of the epigenome. Epigenomics. 2015;7:1051\u201373.","journal-title":"Epigenomics"},{"issue":"1","key":"489_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13072-020-00339-7","volume":"13","author":"M Liu","year":"2020","unstructured":"Liu M, Movahed S, Dangi S, Pan H, Kaur P, Bilinovich SM, et al. DNA looping by two 5-methylcytosine-binding proteins quantified using nanofluidic devices. Epigenetics Chromatin. 2020;13:18.","journal-title":"Epigenetics Chromatin"},{"key":"489_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrg3080","volume":"13","author":"MR Branco","year":"2012","unstructured":"Branco MR, Ficz G, Reik W. Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet. 2012;13:7\u201313.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"489_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13256-018-1690-3","volume":"12","author":"A Ponard","year":"2018","unstructured":"Ponard A, Ferreira-Maldent N, Ertault M, Delain M, Amraoui K, Regina S, et al. Glycemic dysregulation in a patient with type 2 diabetes treated with 5-azacitidine: a case report. J Med Case Rep. 2018;12:199.","journal-title":"J Med Case Rep"},{"issue":"8","key":"489_CR17","first-page":"2989","volume":"33","author":"GNYSZKA AGNIESZKA","year":"2013","unstructured":"DNA Methyltransferase Inhibitors and Their Emerging Role in Epigenetic Therapy of Cancer.","journal-title":"Anticancer Res"},{"issue":"11","key":"489_CR18","doi-asserted-by":"publisher","first-page":"e231903","DOI":"10.1136\/bcr-2019-231903","volume":"12","author":"A Morton","year":"2019","unstructured":"Morton A. Azacitidine-induced hyperglycaemia. BMJ Case Rep. 2019;12:e231903.","journal-title":"BMJ Case Rep"},{"key":"489_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/bcp.14211","volume":"86","author":"J Perino","year":"2020","unstructured":"Perino J, Mottal N, Bohbot Y, Servant V, Berroneau A, Poustis P, et al. Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: case reports and disproportionality analyses in Vigibase. Br J Clin Pharmacol. 2020;86:991\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"489_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S1521-6616(03)00206-7","volume":"109","author":"B Richardson","year":"2003","unstructured":"Richardson B. DNA methylation and autoimmune disease. Clin Immunol. 2003;109:72\u20139.","journal-title":"Clin Immunol"},{"issue":"324","key":"489_CR21","first-page":"930","volume":"2009","author":"M Tahiliani","year":"1979","unstructured":"Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 1979;2009(324):930\u20135.","journal-title":"Science"},{"key":"489_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature13981","volume":"518","author":"BW Carey","year":"2015","unstructured":"Carey BW, Finley LWS, Cross JR, Allis CD, Thompson CB. Intracellular \u03b1-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature. 2015;518:413\u20136.","journal-title":"Nature"},{"key":"489_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA","author":"F Spallotta","year":"2017","unstructured":"Spallotta F, Schn\u00fctgen F. Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from type2 diabetes patients rescue by \u03b1-ketoglutarate and TET-TDG functional reactivation. Circ Res. 2017. https:\/\/doi.org\/10.1161\/CIRCRESAHA.","journal-title":"Circ Res"},{"issue":"4","key":"489_CR24","doi-asserted-by":"publisher","first-page":"e1800970","DOI":"10.1002\/mnfr.201800970","volume":"63","author":"F Ciccarone","year":"2019","unstructured":"Ciccarone F, Castelli S, Ioannilli L, Ciriolo MR. High dietary fat intake affects DNA methylation\/hydroxymethylation in mouse heart: epigenetic hints for obesity-related cardiac dysfunction. Mol Nutr Food Res. 2019;63:e1800970.","journal-title":"Mol Nutr Food Res"},{"key":"489_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/hmg\/ddt453","volume":"23","author":"M Kim","year":"2014","unstructured":"Kim M, Park YK, Kang TW, Lee SH, Rhee YH, Park JL, et al. Dynamic changes in DNA methylation and hydroxymethylation when hES cells undergo differentiation toward a neuronal lineage. Hum Mol Genet. 2014;23:657\u201367.","journal-title":"Hum Mol Genet"},{"key":"489_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature10102","volume":"473","author":"WA Pastor","year":"2011","unstructured":"Pastor WA, Pape UJ, Huang Y, Henderson HR, Lister R, Ko M, et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature. 2011;473:394\u20137.","journal-title":"Nature"},{"key":"489_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature10442","volume":"479","author":"S Shukla","year":"2011","unstructured":"Shukla S, Kavak E, Gregory M, Imashimizu M, Shutinoski B, Kashlev M, et al. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature. 2011;479:74\u20139.","journal-title":"Nature"},{"key":"489_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/dna.2010.1094","volume":"30","author":"C Anastasiadou","year":"2011","unstructured":"Anastasiadou C, Malousi A, Maglaveras N, Kouidou S. Human epigenome data reveal increased CpG methylation in alternatively spliced sites and putative exonic splicing enhancers. DNA Cell Biol. 2011;30:267\u201375.","journal-title":"DNA Cell Biol"},{"key":"489_CR29","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s12265-013-9482-z","volume":"6","author":"E Lara-Pezzi","year":"2013","unstructured":"Lara-Pezzi E, G\u00f3mez-Salinero J, Gatto A, Garc\u00eda-Pav\u00eda P. The alternative heart: impact of alternative splicing in heart disease. J Cardiovasc Transl Res. 2013;6:945\u201355.","journal-title":"J Cardiovasc Transl Res"},{"key":"489_CR30","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1128\/MCB.25.14.6267-6278.2005","volume":"25","author":"AN Ladd","year":"2005","unstructured":"Ladd AN, Taffet G, Hartley C, Kearney DL, Cooper TA. Cardiac tissue-specific repression of CELF activity disrupts alternative splicing and causes cardiomyopathy. Mol Cell Biol. 2005;25:6267\u201378.","journal-title":"Mol Cell Biol"},{"key":"489_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1152\/ajpheart.00758.2018","volume":"317","author":"AM Tabish","year":"2019","unstructured":"Tabish AM, Arif M, Song T, Elbeck Z, Becker RC, Kn\u00f6ll R, et al. Association of intronic DNA methylation and hydroxymethylation alterations in the epigenetic etiology of dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2019;317:168\u201380.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"489_CR32","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ncpcardio1347","volume":"5","author":"D Lebeche","year":"2008","unstructured":"Lebeche D, Davidoff AJ, Hajjar RJ. Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy. Nat Clin Pract Cardiovasc Med. 2008;5:715\u201324.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"489_CR33","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.bbadis.2016.11.007","volume":"1863","author":"JC Zhong","year":"2017","unstructured":"Zhong JC, Zhang ZZ, Wang W, McKinnie SMK, Vederas JC, Oudit GY. Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases. Biochim Biophys Acta Mol Basis Dis. 2017;1863:1942\u201350.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"489_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/s0952-3278(97)90498-1","author":"SA Williams","year":"1997","unstructured":"Williams SA, Tappia PS, Yu C-H, Binaglia L, Panagia V, Dhalla NS. Subcellular alterations in cardiac phospholipase D activity in chronic diabetes. Prostaglandins Leukot Essent Fatty Acids. 1997. https:\/\/doi.org\/10.1016\/s0952-3278(97)90498-1.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"15-16","key":"489_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.lfs.2011.01.023","volume":"88","author":"SC Jeyaraj","year":"2011","unstructured":"Jeyaraj SC, Unger NT, Chotani MA. Rap1 GTPases: an emerging role in the cardiovasculature. Life Sci. 2011;88:645\u201352.","journal-title":"Life Sci"},{"issue":"11","key":"489_CR36","doi-asserted-by":"publisher","first-page":"e50960","DOI":"10.1371\/journal.pone.0050960","volume":"7","author":"W Dong","year":"2012","unstructured":"Dong W, Yang Z, Yang F, Wang J, Zhuang Y, Xu C, et al. Suppression of Rap1 impairs cardiac myofibrils and conduction system in Zebrafish. PLoS ONE. 2012;7:e50960.","journal-title":"PLoS ONE"},{"key":"489_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00557","author":"MB Wysocka","year":"2018","unstructured":"Wysocka MB, Pietraszek-Gremplewicz K, Nowak D. The role of apelin in cardiovascular diseases, obesity and cancer. Front Physiol. 2018. https:\/\/doi.org\/10.3389\/fphys.2018.00557.","journal-title":"Front Physiol"},{"issue":"6","key":"489_CR38","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1161\/HYPERTENSIONAHA.117.10156","volume":"70","author":"ZZ Zhang","year":"2017","unstructured":"Zhang ZZ, Wang W, Jin HY, Chen X, Cheng YW, le Xu Y, et al. Apelin is a negative regulator of angiotensin II-mediated adverse myocardial remodeling and dysfunction. Hypertension. 2017;70:1165\u201375.","journal-title":"Hypertension"},{"key":"489_CR39","doi-asserted-by":"publisher","first-page":"C1011","DOI":"10.1152\/ajpcell.00157.2020","volume":"319","author":"K Zou","year":"2020","unstructured":"Zou K, Turner K, Zheng D, Hinkley JM, Kugler BA, Hornby PJ, et al. Impaired glucose partitioning in primary myotubes from severely obese women with type 2 diabetes. Am J Physiol Cell Physiol. 2020;319:C1011-9.","journal-title":"Am J Physiol Cell Physiol"},{"key":"489_CR40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.diabres.2017.08.018","volume":"133","author":"Y Yue","year":"2017","unstructured":"Yue Y, Meng K, Pu Y, Zhang X. Transforming growth factor beta (TGF-\u03b2) mediates cardiac fibrosis and induces diabetic cardiomyopathy. Diabetes Res Clin Pract. 2017;133:124\u201330.","journal-title":"Diabetes Res Clin Pract"},{"key":"489_CR41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ebiom.2019.08.001","volume":"46","author":"CY Chen","year":"2019","unstructured":"Chen CY, Choong OK, Liu LW, Cheng YC, Li SC, Yen CYT, et al. MicroRNA let-7-TGFBR3 signalling regulates cardiomyocyte apoptosis after infarction. EBioMedicine. 2019;46:236\u201347.","journal-title":"EBioMedicine"},{"key":"489_CR42","doi-asserted-by":"publisher","unstructured":"Yuan Y, Zhu C, Wang Y, Sun J, Feng J, Ma Z, et al. \u03b1-Ketoglutaric acid ameliorates hyperglycemia in diabetes by inhibiting hepatic gluconeogenesis via serpina1e signaling. Sci Adv. 2022. https:\/\/doi.org\/10.1126\/sciadv.abn2879.","DOI":"10.1126\/sciadv.abn2879"},{"issue":"9","key":"489_CR43","doi-asserted-by":"publisher","first-page":"e010012","DOI":"10.1161\/JAHA.118.010012","volume":"8","author":"V Vigorelli","year":"2019","unstructured":"Vigorelli V, Resta J, Bianchessi V, Lauri A, Bassetti B, Agrifoglio M, et al. Abnormal DNA methylation induced by hyperglycemia reduces CXCR4 gene expression in CD34\u00a0+\u00a0stem cells. J Am Heart Assoc. 2019;8:e010012.","journal-title":"J Am Heart Assoc"},{"key":"489_CR44","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.2337\/db14-0231","volume":"63","author":"D Wei","year":"2014","unstructured":"Wei D, Loeken MR. Increased DNA methyltransferase 3b (DNMT3B)-mediated CpG island methylation stimulated by oxidative stress inhibits expression of a gene required for neural tube and neural crest development in diabetic pregnancy. Diabetes. 2014;63:3512\u201322.","journal-title":"Diabetes"},{"key":"489_CR45","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1177\/0192623312438738","volume":"40","author":"PC Mann","year":"2012","unstructured":"Mann PC, Vahle J, Keenan CM, Baker JF, Bradley AE, Goodman DG, et al. International harmonization of toxicologic pathology nomenclature: an overview and review of basic principles. Toxicol Pathol. 2012;40:7S-13S.","journal-title":"Toxicol Pathol"},{"key":"489_CR46","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.freeradbiomed.2016.06.019","volume":"97","author":"S Arkat","year":"2016","unstructured":"Arkat S, Umbarkar P, Singh S, Sitasawad SL. Mitochondrial Peroxiredoxin-3 protects against hyperglycemia induced myocardial damage in diabetic cardiomyopathy. Free Radic Biol Med. 2016;97:489\u2013500.","journal-title":"Free Radic Biol Med"},{"key":"489_CR47","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nature09303","volume":"466","author":"S Ito","year":"2010","unstructured":"Ito S, Dalessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010;466:1129\u201333.","journal-title":"Nature"},{"key":"489_CR48","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1093\/bioinformatics\/btu372","volume":"30","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Lin YH, Johnson TD, Rozek LS, Sartor MA. PePr: a peak-calling prioritization pipeline to identify consistent or differential peaks from replicated ChIP-Seq data. Bioinformatics. 2014;30:2568\u201375.","journal-title":"Bioinformatics"},{"key":"489_CR49","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nprot.2012.012","volume":"7","author":"O Taiwo","year":"2012","unstructured":"Taiwo O, Wilson GA, Morris T, Seisenberger S, Reik W, Pearce D, et al. Methylome analysis using MeDIP-seq with low DNA concentrations. Nat Protoc. 2012;7:617\u201336.","journal-title":"Nat Protoc"},{"key":"489_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fncel.2019.00095","volume":"13","author":"A Perna","year":"2019","unstructured":"Perna A, Alberi LA. TF-chip method for tissue-specific gene targets. Front Cell Neurosci. 2019;13:95.","journal-title":"Front Cell Neurosci"}],"container-title":["Epigenetics &amp; Chromatin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-023-00489-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13072-023-00489-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-023-00489-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T08:13:03Z","timestamp":1751271183000},"score":1,"resource":{"primary":{"URL":"https:\/\/epigeneticsandchromatin.biomedcentral.com\/articles\/10.1186\/s13072-023-00489-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["489"],"URL":"https:\/\/doi.org\/10.1186\/s13072-023-00489-4","relation":{},"ISSN":["1756-8935"],"issn-type":[{"value":"1756-8935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"8 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Animal Ethics Committee (IAEC\/2021\/B-430) and performed following the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}